Drug Compounders To Congress: Stem FDA's Office-Use Rx Requirement

Drug Compounders To Congress: Stem FDA's Office-Use Rx Requirements

A group of of pharmacy and healthcare provider organizations is pushing congressional health care committees to take legislative steps to stop FDA from requiring patient-specific prescriptions for office-use compounding, complaining the agency's approach is barring patient access to urgently-needed antibiotics and goes against congressional intent.